col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


79 Results       Page 1

 [1] 
Wiley: Advanced Science
  original article Date Title Authors   All Authors
1 [GO] 2024―Oct―29 Humoral Immunity Profiling to Pandemic and Bat-Derived Coronavirus Variants: A Geographical Comparison Parinaz Fathi, Andrea Lucia Alfonso, Christina Yek, Zoe Putman, Matthew Drew, Dominic Esposito, et al. (+16)
2 [GO] 2024―Oct―28 Intranasal Multiepitope PD-L1-siRNA-Based Nanovaccine: The Next-Gen COVID-19 Immunotherapy (Adv. Sci. 40/2024) Rita C. Acúrcio, Ron Kleiner, Daniella Vaskovich-Koubi, Bárbara Carreira, Yulia Liubomirski, Carolina Palma, et al. (+17)
3 [GO] 2024―Oct―14 Machine Learning Early Detection of SARS-CoV-2 High-Risk Variants Lun Li, Cuiping Li, Na Li, Dong Zou, Wenming Zhao, Hong Luo, et al. (+4)
4 [GO] 2024―Oct―08 The S2 Pocket Governs the Genus-Specific Substrate Selectivity of Coronavirus 3C-Like Protease Junwei Zhou, Peng Sun, Zhixiang Yang, Taiquan Wang, Jiahui Guo, Runhui Qiu, et al. (+6)
5 [GO] 2024―Oct―07 Broad-Spectrum Engineered Multivalent Nanobodies Against SARS-CoV-1/2 Zhihong Wang, Zhuangzhuang Shi, Xiaochen Liao, Guiqi Quan, Hui Dong, Pinnan Zhao, et al. (+12)
6 [GO] 2024―Oct―01 A Dual-Adjuvanted Parenteral-Intranasal Subunit Nanovaccine generates Robust Systemic and Mucosal Immunity Against SARS-CoV-2 in Mice Bhawana Pandey, Zhengying Wang, Angela Jimenez, Eshant Bhatia, Ritika Jain, Alexander Beach, et al. (+10)
7 [GO] 2024―Sep―25 Miniaturized Modular Click Chemistry-enabled Rapid Discovery of Unique SARS-CoV-2 Mpro Inhibitors With Robust Potency and Drug-like Profile Mianling Yang, Myoung Kyu Lee, Shenghua Gao, Letian Song, Hye-Yeon Jang, Inseong Jo, et al. (+13)
8 [GO] 2024―Sep―20 Lung-Targeted Lipid Nanoparticle-Delivered siUSP33 Attenuates SARS-CoV-2 Replication and Virulence by Promoting Envelope Degradation Yuzheng Zhou, Yujie Liao, Lujie Fan, Xiafei Wei, Qiang Huang, Chuwei Yang, et al. (+7)
9 [GO] 2024―Sep―04 Broad Adaptability of Coronavirus Adhesion Revealed from the Complementary Surface Affinity of Membrane and Spikes Aritz B. García-Arribas, Pablo Ibáñez-Freire, Diego Carlero, Pablo Palacios-Alonso, Miguel Cantero-Reviejo, Pablo Ares, et al. (+9)
10 [GO] 2024―Aug―29 SARS-CoV-2 Evolution: Immune Dynamics, Omicron Specificity, and Predictive Modeling in Vaccinated Populations Xiaohan Zhang, Mansheng Li, Nana Zhang, Yunhui Li, Fei Teng, Yongzhe Li, et al. (+11)
11 [GO] 2024―Aug―08 Intranasal Multiepitope PD-L1-siRNA-Based Nanovaccine: The Next-Gen COVID-19 Immunotherapy Rita C. Acúrcio, Ron Kleiner, Daniella Vaskovich-Koubi, Bárbara Carreira, Yulia Liubomirski, Carolina Palma, et al. (+17)
12 [GO] 2024―Jul―13 Infrared Spectroscopy of SARS-CoV-2 Viral Protein: from Receptor Binding Domain to Spike Protein Tiziana Mancini, Salvatore Macis, Rosanna Mosetti, Nicole Luchetti, Velia Minicozzi, Andrea Notargiacomo, et al. (+5)
13 [GO] 2024―Jul―08 Multi-Omics Analysis by Machine Learning Identified Lysophosphatidic Acid as a Biomarker and Therapeutic Target for Porcine Reproductive and Respiratory Syndrome Hao Zhang, Fangyu Hu, Ouyang Peng, Yihui Huang, Guangli Hu, Usama Ashraf, et al. (+11)
14 [GO] 2024―Jul―03 Correction to “The Role of Host Cell Glycans on Virus Infectivity: The SARS-CoV-2 Case”
15 [GO] 2024―Jun―03 Two-Stage Mixed-Dye-Based Isothermal Amplification with Ribonuclease-Cleavable Enhanced Probes for Dual-Visualization Detection of SARS-CoV-2 Variants of Interest Xiong Ding, Yaru Wang, Yuxin Gui, Chuankun Yang
16 [GO] 2024―Mar―28 Azvudine for the Treatment of COVID-19 in Pre-Existing Cardiovascular Diseases: A Single-Center, Real-World Experience Liu Wu, Zhong-Han He, Ling Huang, Xin Guo, Xu-Yong Li, Hong-Da Zhang, Man-Hua Chen
17 [GO] 2024―Jan―20 Peptide Nucleic Acid Clamp-Assisted Photothermal Multiplexed Digital PCR for Identifying SARS-CoV-2 Variants of Concern Lexiang Zhang, Rokshana Parvin, Siyue Lin, Mingshuo Chen, Ruixuan Zheng, Qihui Fan, Fangfu Ye
18 [GO] 2023―Dec―25 Extracellular Vesicles: The Invisible Heroes and Villains of COVID-19 Central Neuropathology Haiqing Chang, Erya Chen, Yi Hu, Lining Wu, Liyun Deng, Shixin Ye-Lehmann, et al. (+4)
19 [GO] 2023―Dec―18 Mosaic RBD Nanoparticles Elicit Protective Immunity Against Multiple Human Coronaviruses in Animal Models Yanjun Zhang, Jing Sun, Jian Zheng, Suxiang Li, Haiyue Rao, Jun Dai, et al. (+19)
20 [GO] 2023―Oct―21 Dendritic Cell-Mediated Cross-Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS-CoV-2 Rodrigo Lázaro-Gorines, Patricia Pérez, Ignacio Heras-Murillo, Irene Adán-Barrientos, Guillermo Albericio, David Astorgano, et al. (+27)
21 [GO] 2023―Sep―15 Smoke and Spike: Benzo[a]pyrene Enhances SARS-CoV-2 Infection by Boosting NR4A2-Induced ACE2 and TMPRSS2 Expression (Adv. Sci. 26/2023) Wenbin Liu, Yue Zhao, Junyan Fan, Jiaying Shen, Hailin Tang, Wanda Tang, et al. (+15)
22 [GO] 2023―Aug―21 A Suitable Membrane Distance Regulated by the RBD_ACE2 Interaction is Critical for SARS-CoV-2 Spike-Mediated Viral Invasion Mengdan Wu, Wei Li, Sheng Lin, Jiaqi Fan, Lele Cui, Yijuan Xiang, et al. (+8)
23 [GO] 2023―Aug―01 A Mosaic Nanoparticle Vaccine Elicits Potent Mucosal Immune Response with Significant Cross-Protection Activity against Multiple SARS-CoV-2 Sublineages Xiantao Zhang, Shijian Wu, Jie Liu, Ran Chen, Yongli Zhang, Yingtong Lin, et al. (+14)
24 [GO] 2023―Jul―10 Smoke and Spike: Benzo[a]pyrene Enhances SARS-CoV-2 Infection by Boosting NR4A2-Induced ACE2 and TMPRSS2 Expression Wenbin Liu, Yue Zhao, Junyan Fan, Jiaying Shen, Hailin Tang, Wanda Tang, et al. (+15)
25 [GO] 2023―Jun―02 Optimization and Deoptimization of Codons in SARS-CoV-2 and Related Implications for Vaccine Development Xinkai Wu, Ke-jia Shan, Fuwen Zan, Xiaolu Tang, Zhaohui Qian, Jian Lu
26 [GO] 2023―May―24 Direct Quantitation of SARS-CoV-2 Virus in Urban Ambient Air via a Continuous-Flow Electrochemical Bioassay Fuze Jiang, Bei Liu, Yang Yue, Yile Tao, Zhen Xiao, Meng Li, et al. (+7)
27 [GO] 2023―May―19 Repurposing CRISPR/Cas to Discover SARS-CoV-2 Detecting and Neutralizing Aptamers Ju Zhang, Airu Zhu, Miao Mei, Jing Qu, Yalan Huang, Yongshi Shi, et al. (+7)
28 [GO] 2023―May―11 A Newly Identified Spike Protein Targeted Linear B-Cell Epitope Based Dissolvable Microneedle Array Successfully Eliciting Neutralizing Activities against SARS-CoV-2 Wild-Type Strain in Mice Lin Li, Zhongpeng Zhao, Xiaolan Yang, Zhongyi Su, Wendong Li, Shaolong Chen, et al. (+11)
29 [GO] 2023―May―05 A Review of Extracellular Vesicles in COVID-19 Diagnosis, Treatment, and Prevention Peng Su, Yuchen Wu, Feng Xie, Qinghui Zheng, Long Chen, Zhuang Liu, et al. (+3)
30 [GO] 2023―May―03 From Microscopic Droplets to Macroscopic Crowds: Crossing the Scales in Models of Short-Range Respiratory Disease Transmission, with Application to COVID-19 Simon Mendez, Willy Garcia, Alexandre Nicolas
31 [GO] 2023―Apr―29 Oral Fungal Alterations in Patients with COVID-19 and Recovered Patients Xiaobo Hu, Haiyu Wang, Bo Yu, Jia Yu, Haifeng Lu, Junyi Sun, et al. (+8)
32 [GO] 2023―Apr―25 Antiviral Nanobiologic Therapy Remodulates Innate Immune Responses to Highly Pathogenic Coronavirus Xuan Liu, Lunzhi Yuan, Jijing Chen, Yali Zhang, Peiwen Chen, Ming Zhou, et al. (+11)
33 [GO] 2023―Mar―30 CoVSense: Ultrasensitive Nucleocapsid Antigen Immunosensor for Rapid Clinical Detection of Wildtype and Variant SARS-CoV-2 Razieh Salahandish, Jae Eun Hyun, Fatemeh Haghayegh, Hamed Osouli Tabrizi, Shirin Moossavi, Sultan Khetani, et al. (+5)
34 [GO] 2023―Feb―27 Anti-Coronaviral Nanocluster Restrain Infections of SARS-CoV-2 and Associated Mutants through Virucidal Inhibition and 3CL Protease Inactivation Hao Tang, Hongbo Qin, Shiting He, Qizhen Li, Huan Xu, Mengsi Sun, et al. (+9)
35 [GO] 2022―Dec―19 Gossypol Broadly Inhibits Coronaviruses by Targeting RNA-Dependent RNA Polymerases (Adv. Sci. 35/2022) Wenjing Wang, Wenkang Li, Zhiyuan Wen, Chong Wang, Weilong Liu, Yufang Zhang, et al. (+8)
36 [GO] 2022―Nov―24 The Role of Host Cell Glycans on Virus Infectivity: The SARS-CoV-2 Case Silvia Acosta-Gutiérrez, Joseph Buckley, Giuseppe Battaglia
37 [GO] 2022―Nov―15 Rational Development of Hypervalent Glycan Shield-Binding Nanoparticles with Broad-Spectrum Inhibition against Fatal Viruses Including SARS-CoV-2 Variants Ying Li, Shuxin Xu, Qing Ye, Hang Chi, Zhanchen Guo, Jingran Chen, et al. (+5)
38 [GO] 2022―Nov―01 Nebulized mRNA-Encoded Antibodies Protect Hamsters from SARS-CoV-2 Infection Daryll Vanover, Chiara Zurla, Hannah E. Peck, Nichole Orr-Burks, Jae Yeon Joo, Jackelyn Murray, et al. (+15)
39 [GO] 2022―Oct―31 On-Site Quantification and Infection Risk Assessment of Airborne SARS-CoV-2 Virus Via a Nanoplasmonic Bioaerosol Sensing System in Healthcare Settings Guangyu Qiu, Martin Spillmann, Jiukai Tang, Yi-Bo Zhao, Yile Tao, Xiaole Zhang, et al. (+4)
40 [GO] 2022―Oct―21 Gossypol Broadly Inhibits Coronaviruses by Targeting RNA-Dependent RNA Polymerases Wenjing Wang, Wenkang Li, Zhiyuan Wen, Chong Wang, Weilong Liu, Yufang Zhang, et al. (+8)
41 [GO] 2022―Oct―11 Rapid Generation of Circulating and Mucosal Decoy Human ACE2 using mRNA Nanotherapeutics for the Potential Treatment of SARS-CoV-2 Jeonghwan Kim, Antony Jozic, Anindit Mukherjee, Dylan Nelson, Kevin Chiem, Md Siddiqur Rahman Khan, et al. (+3)
42 [GO] 2022―Sep―23 Dynamic Alterations in the Respiratory Tract Microbiota of Patients with COVID-19 and its Association with Microbiota in the Gut (Adv. Sci. 27/2022) Yifei Shen, Fei Yu, Dan Zhang, Qianda Zou, Mengxiao Xie, Xiao Chen, et al. (+20)
43 [GO] 2022―Sep―03 Investigating and Resolving Cardiotoxicity Induced by COVID-19 Treatments using Human Pluripotent Stem Cell-Derived Cardiomyocytes and Engineered Heart Tissues He Xu, Ge Liu, Jixing Gong, Ying Zhang, Shanshan Gu, Zhongjun Wan, et al. (+8)
44 [GO] 2022―Jul―28 Protein Scaffold-Based Multimerization of Soluble ACE2 Efficiently Blocks SARS-CoV-2 Infection In Vitro and In Vivo Alisan Kayabolen, Ugur Akcan, Doğancan Özturan, Hivda Ulbegi-Polat, Gizem Nur Sahin, Nareg Pinarbasi-Degirmenci, et al. (+16)
45 [GO] 2022―Jul―03 Dynamic Alterations in the Respiratory Tract Microbiota of Patients with COVID-19 and its Association with Microbiota in the Gut Yifei Shen, Fei Yu, Dan Zhang, Qianda Zou, Mengxiao Xie, Xiao Chen, et al. (+20)
46 [GO] 2022―Jun―24 TMED3 Complex Mediates ER Stress-Associated Secretion of CFTR, Pendrin, and SARS-CoV-2 Spike Hak Park, Soo Kyung Seo, Ju-Ri Sim, Su Jin Hwang, Ye Jin Kim, Dong Hoon Shin, et al. (+10)
47 [GO] 2022―May―24 Control of COVID-19 Outbreaks under Stochastic Community Dynamics, Bimodality, or Limited Vaccination Björn Goldenbogen, Stephan O. Adler, Oliver Bodeit, Judith A. H. Wodke, Ximena Escalera-Fanjul, Aviv Korman, et al. (+12)
48 [GO] 2022―May―11 Macromolecular Viral Entry Inhibitors as Broad-Spectrum First-Line Antivirals with Activity against SARS-CoV-2 Rüdiger Groß, Lívia Mesquita Dias Loiola, Leila Issmail, Nadja Uhlig, Valentina Eberlein, Carina Conzelmann, et al. (+19)
49 [GO] 2022―Apr―14 Severe Acute Respiratory Syndrome Type 2-Causing Coronavirus: Variants and Preventive Strategies (Adv. Sci. 11/2022) Mehmet Onur Aydogdu, Jennifer L. Rohn, Nazila V. Jafari, Francis Brako, Shervanthi Homer-Vanniasinkam, Mohan Edirisinghe
50 [GO] 2022―Apr―11 Potent Anti-SARS-CoV-2 Efficacy of COVID-19 Hyperimmune Globulin from Vaccine-Immunized Plasma Ding Yu, Yu-Feng Li, Hong Liang, Jun-Zheng Wu, Yong Hu, Yan Peng, et al. (+33)
51 [GO] 2022―Mar―04 Establishment of Human Pluripotent Stem Cell-Derived Skin Organoids Enabled Pathophysiological Model of SARS-CoV-2 Infection (Adv. Sci. 7/2022) Jie Ma, Jia liu, Dunqin Gao, Xiao Li, Qiyu Zhang, Luye Lv, et al. (+13)
52 [GO] 2022―Feb―10 Development of Receptor Binding Domain (RBD)-Conjugated Nanoparticle Vaccines with Broad Neutralization against SARS-CoV-2 Delta and Other Variants Ran Chen, Xiantao Zhang, Yaochang Yuan, Xiaohui Deng, Bolin Wu, Zhihui Xi, et al. (+23)
53 [GO] 2022―Feb―02 Human Organoids and Organs-on-Chips for Addressing COVID-19 Challenges Yaqing Wang, Peng Wang, Jianhua Qin
54 [GO] 2022―Jan―17 Severe Acute Respiratory Syndrome Type 2-Causing Coronavirus: Variants and Preventive Strategies Mehmet Onur Aydogdu, Jennifer L. Rohn, Nazila V. Jafari, Francis Brako, Shervanthi Homer-Vanniasinkam, Mohan Edirisinghe
55 [GO] 2021―Dec―31 Establishment of Human Pluripotent Stem Cell-Derived Skin Organoids Enabled Pathophysiological Model of SARS-CoV-2 Infection Jie Ma, Jia liu, Dunqin Gao, Xiao Li, Qiyu Zhang, Luye Lv, et al. (+13)
56 [GO] 2021―Dec―08 Raman Molecular Fingerprints of SARS-CoV-2 British Variant and the Concept of Raman Barcode Giuseppe Pezzotti, Francesco Boschetto, Eriko Ohgitani, Yuki Fujita, Masaharu Shin-Ya, Tetsuya Adachi, et al. (+6)
57 [GO] 2021―Nov―26 Masks for COVID-19 Wei Deng, Yajun Sun, Xiaoxue Yao, Karpagam Subramanian, Chen Ling, Hongbo Wang, et al. (+9)
58 [GO] 2021―Nov―23 SARS-CoV-2 N Protein Induces Acute Kidney Injury via Smad3-Dependent G1 Cell Cycle Arrest Mechanism Wenbiao Wang, Junzhe Chen, Dingwen Hu, Pan Pan, Liying Liang, Wenjing Wu, et al. (+5)
59 [GO] 2021―Oct―30 Neutralizing Antibodies to SARS-CoV-2 Selected from a Human Antibody Library Constructed Decades Ago Min Qiang, Peixiang Ma, Yu Li, Hejun Liu, Adam Harding, Chenyu Min, et al. (+23)
60 [GO] 2021―Oct―23 Rapid Detection and Inhibition of SARS-CoV-2-Spike Mutation-Mediated Microthrombosis Sandro Satta, Angela Lai, Susana Cavallero, Cayden Williamson, Justin Chen, Ana M. Blázquez-Medela, et al. (+7)
61 [GO] 2021―Oct―21 DNA-Directed Patterning for Versatile Validation and Characterization of a Lipid-Based Nanoparticle Model of SARS-CoV-2 Molly Kozminsky, Thomas R. Carey, Lydia L. Sohn
62 [GO] 2021―Sep―22 Biomaterials and Oxygen Join Forces to Shape the Immune Response and Boost COVID-19 Vaccines (Adv. Sci. 18/2021) Thibault Colombani, Loek J. Eggermont, Zachary J. Rogers, Lindsay G. A. McKay, Laura E. Avena, Rebecca I. Johnson, et al. (+3)
63 [GO] 2021―Sep―22 Collaborative Equilibrium Coupling of Catalytic DNA Nanostructures Enables Programmable Detection of SARS-CoV-2 (Adv. Sci. 18/2021) Yuan Chen, Noah R. Sundah, Nicholas R. Y. Ho, Auginia Natalia, Yu Liu, Qing Hao Miow, et al. (+7)
64 [GO] 2021―Aug―23 Characterization of the Human Oropharyngeal Microbiomes in SARS-CoV-2 Infection and Recovery Patients Ming Gao, Haiyu Wang, Hong Luo, Ying Sun, Ling Wang, Suying Ding, et al. (+13)
65 [GO] 2021―Jul―19 Collaborative Equilibrium Coupling of Catalytic DNA Nanostructures Enables Programmable Detection of SARS-CoV-2 Yuan Chen, Noah R. Sundah, Nicholas R. Y. Ho, Auginia Natalia, Yu Liu, Qing Hao Miow, et al. (+7)
66 [GO] 2021―Jun―28 Combined Metabolic Activators Accelerates Recovery in Mild-to-Moderate COVID-19 Ozlem Altay, Muhammad Arif, Xiangyu Li, Hong Yang, Mehtap Aydın, Gizem Alkurt, et al. (+12)
67 [GO] 2021―Jun―27 Key Considerations for the Development of Safe and Effective SARS-CoV-2 Subunit Vaccine: A Peptide-Based Vaccine Alternative Ahmed O. Shalash, Waleed M. Hussein, Mariusz Skwarczynski, Istvan Toth
68 [GO] 2021―Jun―26 Molecular PET/CT Profiling of ACE2 Expression In Vivo: Implications for Infection and Outcome from SARS-CoV-2 Hua Zhu, Hanwen Zhang, Nina Zhou, Jin Ding, Jinquan Jiang, Teli Liu, et al. (+13)
69 [GO] 2021―May―18 Biomaterials and Oxygen Join Forces to Shape the Immune Response and Boost COVID-19 Vaccines Thibault Colombani, Loek J. Eggermont, Zachary J. Rogers, Lindsay G. A. McKay, Laura E. Avena, Rebecca I. Johnson, et al. (+3)
70 [GO] 2021―May―12 Antiviral and Anti-Inflammatory Treatment with Multifunctional Alveolar Macrophage-Like Nanoparticles in a Surrogate Mouse Model of COVID-19 Bin Li, Wei Wang, Weifeng Song, Zheng Zhao, Qingqin Tan, Zhaoyan Zhao, et al. (+9)
71 [GO] 2021―Feb―10 Rapid and Repetitive Inactivation of SARS-CoV-2 and Human Coronavirus on Self-Disinfecting Anionic Polymers Bharadwaja S.T. Peddinti, Sierra N. Downs, Jiaqi Yan, Steven D. Smith, Reza A. Ghiladi, Vijay Mhetar, et al. (+4)
72 [GO] 2020―Dec―02 SARS-CoV-2: Bioinspired DNase-I-Coated Melanin-Like Nanospheres for Modulation of Infection-Associated NETosis Dysregulation (Adv. Sci. 23/2020) Hee Ho Park, Wooram Park, Yun Young Lee, Hyelim Kim, Hee Seung Seo, Dong Wook Choi, et al. (+7)
73 [GO] 2020―Nov―20 Digital CRISPR/Cas-Assisted Assay for Rapid and Sensitive Detection of SARS-CoV-2 Joon Soo Park, Kuangwen Hsieh, Liben Chen, Aniruddha Kaushik, Alexander Y. Trick, Tza-Huei Wang
74 [GO] 2020―Oct―24 Biomimetic Human Disease Model of SARS-CoV-2 Induced Lung Injury and Immune Responses on Organ Chip System Min Zhang, Peng Wang, Ronghua Luo, Yaqing Wang, Zhongyu Li, Yaqiong Guo, et al. (+10)
75 [GO] 2020―Sep―25 Predicting the Outbreak Risks and Inflection Points of COVID-19 Pandemic with Classic Ecological Theories Zhanshan (Sam) Ma
76 [GO] 2020―Sep―23 MeCas12a, a Highly Sensitive and Specific System for COVID-19 Detection Peixiang Ma, Qingzhou Meng, Baoqing Sun, Bing Zhao, Lu Dang, Mingtian Zhong, et al. (+9)
77 [GO] 2020―Sep―01 Relieving Cost of Epidemic by Parrondo's Paradox: A COVID-19 Case Study Kang Hao Cheong, Tao Wen, Joel Weijia Lai
78 [GO] 2020―Jul―14 A Randomized, Open-label, Controlled Clinical Trial of Azvudine Tablets in the Treatment of Mild and Common COVID-19, A Pilot Study Zhigang Ren, Hong Luo, Zujiang Yu, Jingchao Song, Lan Liang, Ling Wang, et al. (+16)
79 [GO] 2020―Jun―24 Coronavirus in Continuous Flux: From SARS-CoV to SARS-CoV-2 Yetian Dong, Tong Dai, Jun Liu, Long Zhang, Fangfang Zhou
 [1] 

79 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.011 sec